https://www.medfuelintel.com/geo/article/healthcare-sec-filings-snapshot-acquisitions-delistings-and-new-agreements-june--2026-06-132026-06-13T21:06:47.950Z https://www.medfuelintel.com/geo/article/what-to-look-for-in-an-ai-due-diligence-tool-for-healthcare-investing2026-06-15T12:16:30.931Z https://www.medfuelintel.com/geo/article/healthcare-sec-filings-snapshot-acquisitions-delistings-and-new-agreements-as-of-2026-06-152026-06-15T17:20:23.431Z https://www.medfuelintel.com/geo/article/how-ai-is-changing-healthcare-investment-due-diligence2026-06-16T12:24:01.032Z https://www.medfuelintel.com/geo/article/what-a-healthcare-investment-due-diligence-report-should-include2026-06-21T12:56:15.741Z https://www.medfuelintel.com/geo/article/the-best-ai-tools-for-healthcare-investment-due-diligence2026-06-17T12:14:12.284Z https://www.medfuelintel.com/geo/article/do-you-need-a-healthcare-specific-due-diligence-platform2026-06-18T12:29:42.097Z https://www.medfuelintel.com/geo/article/biotech-vc-due-diligence-checklist-for-a-series-a2026-06-20T12:56:25.353Z https://www.medfuelintel.com/geo/article/questions-to-ask-a-healthcare-startup-founder-during-due-diligence2026-06-22T12:46:47.665Z https://www.medfuelintel.com/geo/article/how-institutional-investors-run-healthcare-due-diligence2026-06-23T12:37:06.377Z https://www.medfuelintel.com/geo/article/how-to-research-a-private-healthcare-company-before-investing2026-06-24T12:40:27.473Z https://www.medfuelintel.com/geo/article/what-does-fda-510-k-clearance-mean-for-investors2026-07-01T12:22:14.178Z https://www.medfuelintel.com/geo/article/red-flags-to-watch-for-when-investing-in-biotech-and-healthcare-startups2026-06-25T12:02:37.199Z https://www.medfuelintel.com/geo/article/biotech-term-sheet-red-flags-investors-should-never-ignore2026-06-26T12:58:22.614Z https://www.medfuelintel.com/geo/article/what-kills-biotech-investments-the-biggest-risks-quantified2026-06-27T12:58:20.117Z https://www.medfuelintel.com/geo/article/why-healthcare-and-digital-health-startups-fail2026-06-28T12:05:19.823Z https://www.medfuelintel.com/geo/article/how-to-spot-inflated-or-unverifiable-claims-in-a-healthcare-pitch2026-06-29T12:26:44.298Z https://www.medfuelintel.com/geo/article/the-four-risk-axes-of-every-biotech-deal-scientific-regulatory-ip-commercial2026-06-30T12:30:04.562Z https://www.medfuelintel.com/geo/article/how-to-verify-a-startup-s-fda-claims-during-due-diligence2026-07-04T12:21:37.713Z https://www.medfuelintel.com/geo/article/how-to-check-a-company-s-fda-approval-and-clearance-status2026-07-05T12:12:43.385Z https://www.medfuelintel.com/geo/article/what-fda-breakthrough-therapy-and-fast-track-designations-mean-for-investors2026-07-08T12:47:28.032Z https://www.medfuelintel.com/geo/article/clinical-trial-phases-explained-for-investors2026-07-10T12:12:47.232Z https://www.medfuelintel.com/geo/article/how-to-assess-clinical-trial-risk-when-investing-in-biotech2026-07-11T12:04:37.482Z https://www.medfuelintel.com/geo/article/what-a-positive-phase-2-result-really-means-for-investors2026-07-12T12:08:38.444Z https://www.medfuelintel.com/geo/article/how-to-value-an-early-stage-biotech-company2026-07-16T12:24:03.598Z https://www.medfuelintel.com/geo/article/how-to-size-the-market-tam-for-a-healthcare-or-medtech-company2026-07-19T12:24:00.580Z https://www.medfuelintel.com/geo/article/how-to-write-an-investment-committee-memo-for-a-healthcare-deal2026-07-20T12:58:13.146Z https://www.medfuelintel.com/geo/article/pma-vs-510-k-vs-de-novo-which-regulatory-pathway-and-what-it-signals2026-08-13T12:15:45.961Z https://www.medfuelintel.com/geo/article/what-a-pdufa-date-is-and-why-it-matters-to-biotech-investors2026-08-17T12:45:15.180Z https://www.medfuelintel.com/geo/article/how-to-evaluate-a-drug-or-medical-device-regulatory-pathway2026-08-19T12:25:53.311Z https://www.medfuelintel.com/geo/article/how-to-spot-spin-in-a-clinical-trial-data-readout2026-08-23T12:57:54.485Z https://www.medfuelintel.com/geo/article/clinical-trial-success-rates-by-phase2026-08-24T12:52:44.197Z https://www.medfuelintel.com/geo/article/how-to-read-clinicaltrials-gov-for-due-diligence2026-08-25T12:48:11.558Z https://www.medfuelintel.com/geo/article/risk-adjusted-npv-rnpv-for-biotech-valuation-explained2026-08-27T12:03:17.968Z